Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection

Objective Pseudomonas aeruginosa has been suggested as a major determinant of poor pulmonary outcomes in cystic fibrosis (CF), although other factors play a role. Our objective was to investigate the association of early childhood Pseudomonas infection on differences in lung function in adolescence with CF. Methods Two populations of subjects with CF were studied: from the Gene Modifier Study (GMS), 346 F508del homozygotes with severe vs. mild adolescent lung disease, and from the Colorado Newborn Screen Study (NBS) 172 subjects diagnosed with CF by newborn screening. Associations of Pseudomonas infection and lung function in early childhood with lung function in adolescence were investigated using multivariate linear regression analyses. Results Among GMS subjects, those with severe adolescent lung disease had worse lung function in childhood (FEV1 25 percentage points lower) compared to subjects with mild adolescent lung disease, regardless of early childhood Pseudomonas status. Among NBS subjects, those with lowest adolescent lung function had significantly lower early childhood lung function and faster rate of decline in FEV1 than subjects with highest adolescent lung function; early Pseudomonas infection was not associated with rate of FEV1 decline. The strongest predictor of adolescent lung function was early childhood lung function. Subjects with a higher percentage of cultures positive for Pseudomonas before age 6 or a lower BMI at 2–4 years old also had lower adolescent lung function, though these associations were not as strong as with early childhood lung function. Conclusions In separate analyses of two distinct populations of subjects with CF, we found a strong correlation between lower lung function in early childhood and adolescence, regardless of early childhood Pseudomonas status. Factors in addition to early Pseudomonas infection have a strong impact on lung function in early childhood in CF. Further exploration may identify novel underlying genetic or environmental factors that predispose children with CF to early loss of lung function.

[1]  D. Sanders,et al.  Risk factors for lung function decline in a large cohort of young cystic fibrosis patients , 2015, Pediatric pulmonology.

[2]  S. Sagel,et al.  Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. , 2012, American journal of respiratory and critical care medicine.

[3]  E. Atenafu,et al.  Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[4]  M. Drumm,et al.  Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease , 2011, Pediatric pulmonology.

[5]  M. Schechter,et al.  Genetic and non-genetic determinants of outcomes in cystic fibrosis. , 2009, Paediatric respiratory reviews.

[6]  J. Emerson,et al.  Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. , 2009, The Journal of pediatrics.

[7]  R. Moss.  Infection, inflammation, and the downward spiral of cystic fibrosis lung disease. , 2009, The Journal of pediatrics.

[8]  P. Sly,et al.  Lung function in infants with cystic fibrosis diagnosed by newborn screening. , 2008, American journal of respiratory and critical care medicine.

[9]  M. Seid,et al.  Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. , 2008, The Journal of pediatrics.

[10]  G. Sawicki,et al.  The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis , 2008, Pediatric pulmonology.

[11]  C. Merlo,et al.  Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.

[12]  S. Stanojevic,et al.  Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.

[13]  L. Kalish,et al.  Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients , 2008, Pediatric pulmonology.

[14]  F. Accurso,et al.  Gene modifiers in cystic fibrosis. , 2008, The Journal of clinical investigation.

[15]  J. Ellen,et al.  Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. , 2008, JAMA.

[16]  A. Bush,et al.  Cystic fibrosis , 2007, BMJ : British Medical Journal.

[17]  Stefano Guerra,et al.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study , 2007, The Lancet.

[18]  Charles A. Johnson,et al.  Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. , 2007, The Journal of pediatrics.

[19]  B. Yankaskas,et al.  Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.

[20]  A. Wade,et al.  Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests , 2007, Thorax.

[21]  M. Kosorok,et al.  Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. , 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[22]  J. Carlin,et al.  Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn Screening , 2005, Pediatric pulmonology.

[23]  Michael R Knowles,et al.  Genetic modifiers of lung disease in cystic fibrosis. , 2005, The New England journal of medicine.

[24]  M. Kosorok,et al.  Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. , 2005, JAMA.

[25]  C. Goss,et al.  Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis , 2004, Thorax.

[26]  M. Schechter.  Non-Genetic Influences on Cystic Fibrosis Lung Disease: The Role of Sociodemographic Characteristics, Environmental Exposures, and Healthcare Interventions , 2003, Seminars in respiratory and critical care medicine.

[27]  R. Gibson,et al.  Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management , 2003, Current opinion in pulmonary medicine.

[28]  S. Emerson,et al.  Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study , 2003, The Lancet.

[29]  J. Emerson,et al.  Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[30]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.

[31]  L. Holmberg,et al.  Predictors of deterioration of lung function in cystic fibrosis * , 2002, Pediatric pulmonology.

[32]  Shumei S. Guo,et al.  2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.

[33]  A. Bush,et al.  Six of the best: cystic fibrosis. , 2001, Paediatric respiratory reviews.

[34]  J. Emerson,et al.  Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis * , 2001, Pediatric pulmonology.

[35]  M. Kosorok,et al.  Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition , 2001, Pediatric pulmonology.

[36]  P. Margolis,et al.  The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. , 2001, American journal of respiratory and critical care medicine.

[37]  J. Emerson,et al.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.

[38]  A. Jawad,et al.  Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. , 2000, The Journal of pediatrics.

[39]  T. Hazinski.  Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. , 1999, The Journal of pediatrics.

[40]  M S Pepe,et al.  Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. , 1999, The New England journal of medicine.

[41]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[42]  P. Davis.  The decline and fall of pulmonary function in cystic fibrosis: new models, new lessons. , 1997, The Journal of pediatrics.

[43]  M. Corey,et al.  Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. , 1997, The Journal of pediatrics.

[44]  B. Kerem,et al.  Correlation between genotype and phenotype in patients with cystic fibrosis. , 1994, The New England journal of medicine.

[45]  H. Heijerman,et al.  Correlation between genotype and phenotype in patients with cystic fibrosis. , 1994, The New England journal of medicine.

[46]  David Wypij,et al.  Pulmonary function between 6 and 18 years of age , 1993, Pediatric pulmonology.

[47]  M. Rosenfeld,et al.  Evolution of airway microbiology in the infant with cystic fibrosis: role of nonpseudomonal and pseudomonal pathogens. , 1992, Seminars in respiratory infections.

[48]  F. Accurso,et al.  Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. , 1991, The New England journal of medicine.

[49]  F. Accurso,et al.  Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. , 1991, The Journal of pediatrics.

[50]  Jow.  Kendig's Disorders of the Respiratory Tract in Children , 1991 .

[51]  M. Hibbert,et al.  Tracking of lung function in healthy children and adolescents , 1990, Pediatric pulmonology.

[52]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.